The effects of CXCL12 and CXCL12-mediated signaling pathways in breast cancer are multifaceted and highly context-dependent, varying among different molecular subtypes, stages of tumor progression, and the microenvironmental context. The gene discussed is CXCL12; the disease is breast cancer.